Filing Details

Accession Number:
0001209191-22-002462
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-07 17:12:28
Reporting Period:
2021-12-01
Accepted Time:
2022-01-07 17:12:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1684087 Caroline Young 2525 West End Avenue
Suite 950
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-01 18 $4.14 14,401 No 4 P Direct
Common Stock Acquisiton 2021-12-02 18 $3.84 14,419 No 4 P Direct
Common Stock Acquisiton 2021-12-03 18 $4.47 14,437 No 4 P Direct
Common Stock Acquisiton 2021-12-06 18 $4.46 14,455 No 4 P Direct
Common Stock Acquisiton 2021-12-07 18 $5.61 14,473 No 4 P Direct
Common Stock Acquisiton 2021-12-08 18 $6.15 14,491 No 4 P Direct
Common Stock Acquisiton 2021-12-09 18 $5.81 14,509 No 4 P Direct
Common Stock Acquisiton 2021-12-10 18 $4.82 14,527 No 4 P Direct
Common Stock Acquisiton 2021-12-13 30 $4.36 14,557 No 4 P Direct
Common Stock Acquisiton 2021-12-14 30 $4.28 14,587 No 4 P Direct
Common Stock Acquisiton 2021-12-15 30 $4.29 14,617 No 4 P Direct
Common Stock Acquisiton 2021-12-16 50 $4.53 14,667 No 4 P Direct
Common Stock Acquisiton 2021-12-17 50 $4.17 14,717 No 4 P Direct
Common Stock Acquisiton 2021-12-20 60 $4.33 14,777 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.